Cynosure, Inc. Establishes Wholly Owned Subsidiary In China

WESTFORD, Mass., Dec. 7 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO - News), a leading developer and manufacturer of lasers and pulsed light sources, today announced that it has become the first U.S. aesthetic laser company to have a wholly owned subsidiary in the People's Republic of China. Cynosure has acquired the remaining 48% interest in Suzhou Cynosure Medical Devices, Co., a joint venture with Suzhou 66 Vision-Tech Co., Ltd., and will operate the company as a wholly owned subsidiary of Cynosure, Inc. that will be called Cynosure China. "Our wholly owned subsidiary represents an opportunity to leverage the strong customer relationships we have established over the course of our successful joint venture with Suzhou 66 Vision-Tech," said Cynosure President and Chief Executive Officer Michael Davin. "With the acquisition of the remaining interest in Cynosure China, our strategy is to build long-term marketing momentum by emphasizing our reputation for providing patients with outstanding results and enabling our customers to build their practices with a variety of aesthetic laser offerings. Our newest flagship products are currently in the regulatory review process in China, and we expect to begin receiving market approvals there over the next 12-15 months."

Cynosure China currently employs 15 people. The address and contact details for the office are:

5th Floor, Yuan Dong Da Sha 251 Chang Xu Road Suzhou 215008, Jiangsu People's Republic of China Tel: +86 (512) 655 17051 Fax: +86 (512) 655 78485

About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse-dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.

For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosurelaser.com.

Any statements in this press release about future expectations, plans and prospects for Cynosure China, including statements containing the words "believes," "anticipates," "plans," "expects," "will," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including our history of operating losses, our reliance on sole source suppliers, competition in the aesthetic laser industry, economic, market, technological and other factors discussed in Cynosure's Annual Report on Form 10-K filed with the SEC. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.

Contact:

Scott Solomon Vice President Sharon Merrill Associates, Inc. 617.542.5300 cyno@investorrelations.com

Source: Cynosure, Inc.

>>> Discuss This Story